|
Thrombosis risk factors
Citations 1-10 of 50 total displayed.
|
Most recent content
(1 Dec 2008):
|
- Original Contributions
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation: How Will Screening With Genetics and Imaging Help? • Supplemental Appendix
- Mark H. Eckman, Lawrence K.S. Wong, Yannie O.Y. Soo, Wynnie Lam, Song Ran Yang, Steven M. Greenberg, and Jonathan Rosand
Stroke 39: 3308 -3315; published online before print as doi:10.1161/STROKEAHA.108.523159
[Abstract]
[Full text]
|
Past content
(since Jan 2001):
|
- Articles
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation. How Will Screening With Genetics and Imaging Help?
- Mark H. Eckman, Lawrence K.S. Wong, Yannie O.Y. Soo, Wynnie Lam, Song Ran Yang, Steven M. Greenberg, and Jonathan Rosand
Stroke published October 9, 2008, doi:10.1161/STROKEAHA.108.523159
[Abstract]
- Original Contributions
Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation
- Gregory Y.H. Lip, Deirdre Lane, Carl Van Walraven, and Robert G. Hart
Stroke 37: 2294 -2300; published online before print as doi:10.1161/01.STR.0000236840.00467.84
[Abstract]
[Full text]
- Articles
Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation
- Gregory Y.H. Lip, Deirdre Lane, Carl Van Walraven, and Robert G. Hart
Stroke published August 3, 2006, doi:10.1161/01.STR.0000236840.00467.84
[Abstract]
- Original Contributions
Translating the Results of Randomized Trials into Clinical Practice: The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation
- Elaine M. Hylek, James D’Antonio, Carmella Evans-Molina, Carol Shea, Lori E. Henault, and Susan Regan
Stroke 37: 1075 -1080; published online before print as doi:10.1161/01.STR.0000209239.71702.ce
[Abstract]
[Full text]
- Articles
Translating the Results of Randomized Trials into Clinical Practice. The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation
- Elaine M. Hylek, James D’Antonio, Carmella Evans-Molina, Carol Shea, Lori E. Henault, and Susan Regan
Stroke published March 9, 2006, doi:10.1161/01.STR.0000209239.71702.ce
[Abstract]
- Progress Reviews
Thyroid Diseases and Cerebrovascular Disease
- A. Squizzato, V.E.A. Gerdes, D.P.M. Brandjes, H.R. Büller, and J. Stam
Stroke 36: 2302 -2310; published online before print as doi:10.1161/01.STR.0000181772.78492.07
[Abstract]
[Full text]
- Articles
Thyroid Diseases and Cerebrovascular Disease
- A. Squizzato, V. E.A. Gerdes, D. P.M. Brandjes, H. R. Büller, and J. Stam
Stroke published September 22, 2005, doi:10.1161/01.STR.0000181772.78492.07
[Abstract]
- Original Contributions
Thrombotic Risk Factors In Primary Antiphospholipid Syndrome: A 5-Year Prospective Study
- Maurizio Turiel, Piercarlo Sarzi-Puttini, Rossana Peretti, Edoardo Rossi, Fabiola Atzeni, Wendy Parsons, and Andrea Doria
Stroke 36: 1490 -1494; published online before print as doi:10.1161/01.STR.0000170645.40562.09
[Abstract]
[Full text]
- Articles
Thrombotic Risk Factors In Primary Antiphospholipid Syndrome. A 5-Year Prospective Study
- Maurizio Turiel, Piercarlo Sarzi-Puttini, Rossana Peretti, Edoardo Rossi, Fabiola Atzeni, Wendy Parsons, and Andrea Doria
Stroke published June 9, 2005, doi:10.1161/01.STR.0000170645.40562.09
[Abstract]
|
|
